Viatris Inc.: Leerink Partners raises target price to $24 from $22
VTRS•Leerink Partners raised its target price for Viatris to $24 from $22.
Related News

GM plans 20% boost in robotics as factory costs rise
GM•

Cognition Therapeutics highlights blood test screening efficiencies in Phase 2 Alzheimer's trial
CGTX•

Deals of the day: Mergers and acquisitions
MDLZ•

PowerBank attributes 78.1% revenue drop to lower EPC and development fees
SUUN•

FDA clears Medtronic’s Hugo robotic surgery system for general surgery
MDT•